66-Year-Old Woman With Painless Vesicular Lesions

Bardia, Aditya; Swanson, Elizabeth A.; Thomas, Kris G.
July 2009
Mayo Clinic Proceedings;Jul2009, Vol. 84 Issue 7, p639
Academic Journal
The article explores the condition of a 66-year-old woman with a one month history of painless vesicular lesions on her hands. The patient's urine appears red-tinged with her first morning void. A tense blister on the lateral surface of the left index finger of the patient was revealed on physical examination. A pattern suggestive of Porphyria cutanea tarda (PCT) was found after checking urine and fecal stool samples for porphyrin subanalysis.


Related Articles

  • CYP1A21F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda. Wickliffe, Jeffrey K.; Abdel-Rahman, Sherif Z.; Chul Lee; Kormos-Hallberg, Csilla; Sood, Gagan; Rondelli, Catherine M.; Grady, James J.; Desnick, Robert J.; Anderson, Karl E. // Molecular Medicine;Mar/Apr2011, Vol. 17 Issue 3/4, p241 

    Porphyria cutanea tarda (PCT) is a cutaneous porphyria with sporadic (type 1) and familial (type 2) subtypes, both resulting from decreased hepatic uroporphyrinogen decarboxylase (UROD) activity. Environmental and genetic factors are involved in the development of PCT, and genetic variants in...

  • porphyria.  // Taber's Cyclopedic Medical Dictionary;2005, p1733 

    A definition of the term "porphyria" is presented. It refers to a group of disorders which result from a disturbance in porphyrin metabolism, causing increased formation and excretion of porphyrin or its precursors. It is caused by a disturbance in liver metabolism such as occurs following...

  • De Novo Mutation Found in the Porphobilinogen Deaminase Gene in Slovak Acute Intermittent Porphyria Patient: Molecular Biochemical Study. Ulbrichova, D.; Flachsova, E.; Hrdinka, M.; Saligova, J.; Bazar, J.; Raman, C. S.; Martasek, Pavel // Physiological Research;2006 Supplement, Vol. 55, pS145 

    The porphyrias are group of mostly inherited disorders in which a specific spectrum of accumulated and excreted porphyrins and heme precursors are associated with characteristic clinical features. There are eight enzymes involved in the heme synthesis and defects in seven of them cause...

  • porphyria. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p619 

    An encyclopedia entry for "porphyria" is presented. It refers to a group of rare disorders caused by the accumulation of substances known as porphyrins. Porphyrins are chemicals formed in the body during the manufacture of haem. People affected with the disease have a rash or blistering brought...

  • porphyruria.  // Taber's Cyclopedic Medical Dictionary;2005, p1734 

    A definition of the term "porphyruria" is presented. It refers to porphyrinuria.

  • Fast track to the porphyrias. Phillips, John D.; Kushner, James P. // Nature Medicine;Oct2005, Vol. 11 Issue 10, p1049 

    Focuses on the mechanistic basis for acute porphyrias. Syndrome caused by the neurotoxic effects of precursors to porphyrins; Functions mediated by hemoglobin and other hemoproteins; Signs and symptoms of porphyrias.

  • porphyria.  // Royal Society of Medicine: Medicines;2002, p446 

    The article presents information on porphyrias, a relatively uncommon disease states characterized by disturbed metabolism of the pigment haem which occurs in the blood pigment, leading to the accumulation in the body of porphyrins. The accumulation of porphyrins in the body causes red, brown or...

  • Treatment of the Porphyrias: Mechanisms of Action. Bickers, David R. // Journal of Investigative Dermatology;Jul81, Vol. 77 Issue 1, p107 

    The porphyrias are diseases that result from inherited or acquired abnormalities of porphyrin-heme synthesis in the liver and the bone marrow. Only the hepatic porphyrias are known to be aggravated by exposure to a variety of exogenous drugs and chemicals. Simple avoidance of these agents will...

  • Watson-Schwartz test.  // Taber's Cyclopedic Medical Dictionary;2005, p2344 

    A definition of the term "Watson-Schwartz test" is presented. It refers to a test used to distinguish between porphobilinogen and urobilinogen in acute porphyria. This test was developed by the U.S. physicians Cecil J. Watson and Samuel Schwartz.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics